- Home
- TBBB vs APLS Comparison
TBBB vs APLS Comparison
Compare TBBB & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBBB
- APLS
- Stock Information
- Founded
- TBBB 2004
- APLS 2009
- Country
- TBBB Mexico
- APLS United States
- Employees
- TBBB 21924
- APLS N/A
- Industry
- TBBB
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- TBBB
- APLS Health Care
- Exchange
- TBBB NYSE
- APLS Nasdaq
- Market Cap
- TBBB 3.1B
- APLS 3.3B
- IPO Year
- TBBB 2024
- APLS 2017
- Fundamental
- Price
- TBBB $25.99
- APLS $18.20
- Analyst Decision
- TBBB Buy
- APLS Buy
- Analyst Count
- TBBB 4
- APLS 18
- Target Price
- TBBB $33.50
- APLS $45.59
- AVG Volume (30 Days)
- TBBB 733.5K
- APLS 2.8M
- Earning Date
- TBBB 04-09-2025
- APLS 05-06-2025
- Dividend Yield
- TBBB N/A
- APLS N/A
- EPS Growth
- TBBB N/A
- APLS N/A
- EPS
- TBBB 0.12
- APLS N/A
- Revenue
- TBBB $2,756,534,823.00
- APLS $781,367,000.00
- Revenue This Year
- TBBB $30.79
- APLS $12.71
- Revenue Next Year
- TBBB $27.03
- APLS $20.93
- P/E Ratio
- TBBB $225.65
- APLS N/A
- Revenue Growth
- TBBB 30.31
- APLS 97.02
- 52 Week Low
- TBBB $19.31
- APLS $17.49
- 52 Week High
- TBBB $35.22
- APLS $53.06
- Technical
- Relative Strength Index (RSI)
- TBBB N/A
- APLS 28.14
- Support Level
- TBBB N/A
- APLS $18.00
- Resistance Level
- TBBB N/A
- APLS $19.71
- Average True Range (ATR)
- TBBB 0.00
- APLS 1.63
- MACD
- TBBB 0.00
- APLS -0.16
- Stochastic Oscillator
- TBBB 0.00
- APLS 10.98
About TBBB BBB FOODS INC
BBB Foods Inc is a company offering grocery hard discount model in Mexico. Also that operates through three subsidiaries namely Tiendas Tres B , Tiendas BBB and Desarrolladora Tres BSA de CV of which the main activity of Tiendas Tres B is the sale, purchase, distribution and marketing of all types of products, items and goods, as well as the establishment, and operation of individual stores and distribution centers for the sale of such products.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.